Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methamphetamine hydrochloride
Drug ID BADD_D01408
Description Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug. It is a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse.
Indications and Usage For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.
Marketing Status approved; illicit
ATC Code N06BA03
DrugBank ID DB01577
KEGG ID D02242
MeSH ID D008694
PubChem ID 66124
TTD Drug ID D0P6UB
NDC Product Code 70868-820; 61960-6030; 53834-501; 0054-0389; 68308-115
UNII 997F43Z9CV
Synonyms Methamphetamine | Desoxyephedrine | Metamfetamine | Methylamphetamine | N-Methylamphetamine | N Methylamphetamine | Deoxyephedrine | Desoxyn | Madrine | Methamphetamine Hydrochloride | Hydrochloride, Methamphetamine
Chemical Information
Molecular Formula C10H16ClN
CAS Registry Number 51-57-0
SMILES CC(CC1=CC=CC=C1)NC.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blood pressure increased13.14.03.005---
Constipation07.02.02.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dry mouth07.06.01.002--
Dysgeusia17.02.07.003; 07.14.03.001--
Dysphoria19.04.02.004---
Euphoric mood19.04.02.006--
Gastrointestinal disorder07.11.01.001---
Headache17.14.01.001--
Insomnia19.02.01.002; 17.15.03.002--
Palpitations02.11.04.012--
Restlessness19.11.02.002; 17.02.05.021--
Tachycardia02.03.02.007---
Tremor17.01.06.002--
Urticaria23.04.02.001; 10.01.06.001--
Growth retardation15.03.05.016; 14.03.02.031; 05.03.02.007--
Libido disorder21.03.02.006; 19.08.03.004---
Erectile dysfunction21.03.01.007; 19.08.04.001--
Device stimulation issue27.01.02.005---
The 1th Page    1    Total 1 Pages